This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Patients with node-positive breast cancer who are downstaged after neoadjuvant chemotherapy had low recurrence rates after targeted axillary dissection or sentinel lymph node biopsy.
Medscape Medical News